Greco-Hainsworth Tennessee Oncology Centers for Research (GHCR)

Nashville, Tennessee 37203

0 studies enrolling now · 1 studies all time

What they study most

B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma

Studies at this site

• A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) — Running, not enrolling